Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape. [electronic resource]
Producer: 20180305Description: R151-R159 p. digitalISSN:- 1460-2083
- Animals
- Central Nervous System -- metabolism
- Disease Models, Animal
- Exons
- Humans
- Mice
- Motor Neurons -- metabolism
- Muscular Atrophy, Spinal -- genetics
- Oligodeoxyribonucleotides, Antisense -- genetics
- Oligonucleotides -- therapeutic use
- Oligonucleotides, Antisense -- administration & dosage
- RNA, Messenger -- genetics
- Spinal Cord -- metabolism
- Survival of Motor Neuron 1 Protein -- genetics
- Survival of Motor Neuron 2 Protein -- genetics
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.